OCTAGON RESEARCH SOLUTIONS IMPLEMENTS SAS TECHNOLOGY TO REVOLUTIONIZE CDISC SDTM LEGACY CONVERSION OFFERINGS
WAYNE, PA - April 11, 2005 - Octagon Research Solutions, the leader in the electronic transformation of clinical R&D, today announced that it is implementing the SAS® Enterprise ETL Server to facilitate the automated conversion of legacy data to CDISC compliant formats. The new offering is targeted toward biotechnology and pharmaceutical companies that are moving forward with the implementation of CDISC data standards. These organizations often have significant amounts of existing legacy data that must be converted prior to submission to health authorities.
The implementation of SAS® Enterprise ETL Server enables the automation of traditional data conversion processes that often require manual intervention, considerable programming resources, and significant validation. Tom Guinter, vice president of clinical data strategies at Octagon noted, "Octagon's Clinical Data Strategies Group is committed to developing innovative solutions that help our clients leverage emerging data standards throughout the eSubmission process. The use of SAS Enterprise ETL Server aligns with our strategic goals and offers seamless integration with our current SAS processes."
Ed Helton, SAS' chief strategist for regulatory and biomedical affairs and a member of the CDISC board of directors, commented, "We are pleased to see Octagon utilizing the power of SAS to advance industry standards. Such standards breed new opportunities for automation that ultimately result in recurring efficiencies and enhanced quality throughout the process."
The CDISC Study Data Tabulation Model (SDTM) was designed to improve communications between sponsor organizations and regulatory authorities. Industry-wide acceptance of the model has been increasing as industry and regulatory authorities face the challenges of analyzing pooled data from multiple studies. Frank Newby, vice president, education and member relations, CDISC observed, "The CDISC data standards, specifically SDTM, will allow for greater efficiencies in the drug development and approval process. Innovative solutions that facilitate legacy conversions will aid in the implementation of those standards."
About Octagon Research Solutions, Inc.
Octagon is a leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and creative use of technology. Octagon is headquartered in King of Prussia, PA, with an office in Boston, MA. For more information please visit www.octagonresearch.com.
About SAS
SAS is the market leader in providing a new generation of business intelligence software and services that create true enterprise intelligence. SAS solutions are used at more than 40,000 sites – including 96 of the top 100 companies on the FORTUNE Global 500® – to develop more profitable relationships with customers and suppliers; to enable better, more accurate and informed decisions; and to drive organizations forward. SAS is the only vendor that completely integrates leading data warehousing, analytics and traditional BI applications to create intelligence from massive amounts of data. For nearly three decades, SAS has been giving customers around the world The Power to Know ®.
About CDISC
CDISC is an open, multidisciplinary, non-profit organization committed to the development of worldwide standards to support the electronic acquisition, exchange, submission and archiving of clinical trials data and metadata for medical and biopharmaceutical product development. The mission of CDISC is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. For more information about CDISC, visit the website at http://www.cdisc.org.
|
